Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Receives First $2M of $4M Loan From State of Connecticut

NEW YORK (GenomeWeb) – Vermillion said today that it has received a $2 million disbursement of a loan totaling as much as $4 million from the Connecticut Department of Economic and Community Development.

The company plans to use the funds primarily to build its new Trumbull, Connecticut facility, which will include laboratory and information technology infrastructure.

The remaining $2 million will be disbursed if and when Vermillion meets future milestones. Additionally, Vermillion may be eligible for forgiveness of up to $2 million of the loan's principal if it meets certain job creation and retention milestones as measured by March 1, 2018.

"This loan expands our cash balance and operating runway with non-dilutive financing," Vermilion President and CEO Valerie Palmieri said in a statement. "We look forward to utilizing the proceeds from this loan to make important investments to enhance our Northeast commercialization, strategic partnerships, and leverage operating efficiencies."

The 10-year loan carries a fixed interest rate of 2 percent per year.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more